FMISO-PET in Brain Tumors and SCS Effect

NCT01868906 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Isotope (FMISO) production is no longer available in our country.

Conditions

Malignant Glioma

Interventions

DRUG: 18F-FMISO
PROCEDURE: PET without SCS
DEVICE: SCS
PROCEDURE: PET without/with SCS
RADIATION: Radiotherapy
DRUG: Temozolomide

Sponsor

Bernardino Clavo, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]